Latest / PETRI DISH PERSPECTIVES
May 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail
Welcome to your essential overview of the global biotech and pharmaceutical landscape for May 2026!
This month was dominated by a wave of aggressive cross-border M&A and strategic capital deployment, as pharma giants pivoted to secure the next generation of oncology, metabolic, and infectious disease assets. From high-stakes acquisitions aimed at building comprehensive "acute care" architectures to massive investments in generative AI-driven discovery engines, the industry has clearly shifted toward a model of integrated precision, prioritizing both the speed of research and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.